Future Medicines Summer School
Gene & Cell Therapies
Experience the inspiring and international environment at Utrecht University during the second edition of the Future Medicines Summer School from 6th - 10th July 2020! Gene therapy, cell therapy and tissue engineering fall under the new class of "advanced therapy medicinal products", which are hot topics in many research fields. Advanced therapies provide radical treatment options for numerous diseases and injuries, ranging from skin burns, Alzheimer’s, cystic fibrosis or cancer, suggesting that we have entered a new era of medicine.
Join the "Future Medicines Summer School - Gene & Cell Therapies" to learn about the promises and challenges of advanced therapies throughout the drug life cycle. How do advanced therapies differ from conventional molecular approaches? What steps are needed to get advanced therapies from bench to bedside? 2019 was the year of the first completely individual therapy: Milasen. Get more information about the Future Medicines Summer School on the official Utrecht Summer School website. Or ask one of the Future Medicines Fellows
A flyer can be found here. Feel free to distribute it. The day to day programme can be found below.
Day 1
General introduction and an introduction to the case studies. The day also includes a broad debate with multiple stakeholders considering the opportunities and hurdles with ATMP development and use.
Day 2
An introduction to the topics to be delved in to during the week, including a historic overview and ‘setting’ of the scene. Cellular biology of healthy and diseased cells will be discussed.
Day 3
Dedicated to novel cell therapies. We will be discussing the use of hematopoietic and induced pluripotent stem cells, as well as regenerative medicine techniques. Moreover, we will go into the lab and start with a practical introduction to a modern day gene editing technique; CRISPR/CAS.
Day 4
A critical look at the way gene therapies are administered to patients. A general overview of the gene therapy field will be followed by more specific subjects such as in- and ex-vivo, viral and non-viral delivery of the therapies.
Day 5
An exploration of the immune system and human microbiome as a therapeutic target and medium. Speakers will show how the immune system can be modulated by the use of pro- and prebiotics as well as fecal matter transplantations.